@RaceOncology is this ethics application more complex than prior applications (e.g. EMD AML and Observational Cardioprotection trials) due to the new formulation, trial design, need to monitor both cardio-protection and anti-cancer parameters etc.? Or are all ethics applications a similar level of work and level of documentation?
Thanks in advance.
@RaceOncology is this ethics application more complex than prior...
-
- There are more pages in this discussion • 296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.085(5.80%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $246.4K | 163.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 5483 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |